| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.51M | - | |
| VP | 153.9K | $12.50M | -3,500 | |
| Other | 87.3K | $7.09M | - | |
| VP | 73.6K | $5.97M | -15,000 | |
| CFO | 70.1K | $5.69M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $19.33 | $96,650.50 | -1.5% | |
| Feb 11, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 1,632 | $23.34 | $38,097.08 | -1.1% | |
| Feb 10, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $23.88 | $119,383.50 | -1.6% | |
| Jan 29, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $20.34 | $101,701.00 | -1.6% | |
| Jan 20, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $20.41 | $102,042.50 | -1.6% | |
| Jan 14, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 12,500 | $19.25 | $240,618.75 | -4.0% | |
| Jan 4, 2021 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $20.23 | $101,135.00 | -1.6% | |
| Dec 31, 2020 | Henderson John T65 | Director | Sale+OE | 858 | $20.31 | $17,425.98 | -48.8% | |
| Dec 16, 2020 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $20.51 | $102,551.00 | -1.6% | |
| Dec 15, 2020 | Gage L Patrick45 | Director | Sale+OE | 7,716 | $21.00 | $162,038.31 | -27.1% |